REC-994

· Recursion Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REC-994, covering 2025-08-06 to 2025-08-06. Get the full timeline:

Most recent: Clinical Trial Update: The Symptomatic Cerebral Cavernous Malformation Trial of REC-994 [Phase 2]